The effect of a pre-scheduled appointment on attendance in a population-based mammography screening programme
European Journal of Public Health · 2023
DOI: 10.1093/eurpub/ckad137 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Public Health, 2023. Verfasst von Mathijs M Goossens und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Vrije Universiteit Brussel, Brussels, Belgium. Hauptthemen laut MEDLINE: Breast Neoplasms, Mammography. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The national and regional funders of the PMSP ('Vlaamse Overheid' and 'Rijksinstituut voor Ziekte- en Invaliditeitsverzekering'), PMSP.
Abstract (Originalsprache)
Background
Pre-scheduled appointments can increase attendance in breast cancer screening programmes compared to ‘open invitations’ but relatively few randomized controlled trials exist. We investigated the effect of a pre-scheduled appointment on uptake in the Flemish population-based mammography screening programme.
Methods
Between September and December 2022, a total of 4798 women were randomly assigned to receive either a pre-scheduled appointment or open invitation. The difference in attendance was compared with Poisson regression analysis for the primary endpoint (attendance ≤92 days after date of invitation), yielding relative risks (RRs). This was done separately for three groups: women invited to a mobile unit and a history of nonattendance (group M-NA); women invited to a hospital-based unit and a history of nonattendance (group HB-NA); women invited to a hospital-based unit and a history of irregular attendance (group HB-IA). There were no women invited to a mobile unit and a history of irregular attendance.
Results
The RRs in favour of the pre-scheduled appointment were 2.3 [95% confidence interval (CI) 1.80–2.88], 1.8 (95% CI 1.07–2.97) and 1.8 (95% CI 1.43–2.39), for groups M-NA, HB-NA and HB-IA, respectively. We found no statistically significant difference between the various RRs. The respective absolute gains in attendance between pre-scheduled appointment and open invitation were 8.3%, 4.4% and 15.8%.
Conclusions
Sending an invitation with a pre-scheduled appointment is an effective tool to increase screening attendance in both mobile and hospital-based screening units. The pre-scheduled appointment is associated with a considerable absolute gain in attendance which varies depending on the screening history.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiology, Vrije Universiteit Brussel, Brussels, Belgium.
- Centrum voor Kankeropsporing (Centre for Cancer Detection), Brugge, Belgium.
- Department of Radiology, University Hospital Leuven, Campus St. Rafael, Leuven, Belgium.
- Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.
- Dutch Expert Centre for Screening, Nijmegen, The Netherlands.
Förderung
- The national and regional funders of the PMSP ('Vlaamse Overheid' and 'Rijksinstituut voor Ziekte- en Invaliditeitsverzekering')
- PMSP
Zitieren
APA
Goossens, M. M., Kellen, E., Broeders, M. J. M., Vandemaele, E., Jacobs, B., & Martens, P. (2023). The effect of a pre-scheduled appointment on attendance in a population-based mammography screening programme. European Journal of Public Health. https://doi.org/10.1093/eurpub/ckad137
Vancouver
Goossens MM, Kellen E, Broeders MJM, Vandemaele E, Jacobs B, Martens P. The effect of a pre-scheduled appointment on attendance in a population-based mammography screening programme. European Journal of Public Health. 2023. doi:10.1093/eurpub/ckad137
BibTeX
@article{Goossens2023,
author = {Goossens, Mathijs M and Kellen, Eliane and Broeders, Mireille J M and Vandemaele, Els and Jacobs, Brenda and Martens, Patrick},
title = {The effect of a pre-scheduled appointment on attendance in a population-based mammography screening programme},
journal = {European Journal of Public Health},
year = {2023},
doi = {10.1093/eurpub/ckad137}
}
EUVIMED